![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna¿s pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Show more
Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome PR Newswire EMERYVILLE, Calif., July 15, 2024 The application...
Kyverna's KYV-101 Receives U.S. FDA IND Clearance for Treatment of Patients With Treatment-Refractory Stiff-Person Syndrome in the KYSA-8 Phase 2 Trial PR Newswire EMERYVILLE, Calif., June 20...
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome Published in Proceedings of the National Academy of Sciences (PNAS) PR Newswire EMERYVILLE...
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology PR Newswire EMERYVILLE, Calif., June 10, 2024...
Kyverna Therapeutics to Present Data on 50 Patient Experience at Symposium at EULAR 2024 PR Newswire EMERYVILLE, Calif., June 7, 2024 Data to include insights from 12 indications from more than...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.26 | 29.5424836601 | 7.65 | 10.44 | 7.39 | 509686 | 9.15345351 | CS |
4 | 2.09 | 26.726342711 | 7.82 | 10.44 | 6.75 | 600666 | 8.0203931 | CS |
12 | -9.4 | -48.6794407043 | 19.31 | 19.63 | 6.75 | 604441 | 11.30854605 | CS |
26 | -24.34 | -71.0656934307 | 34.25 | 35.01 | 6.75 | 522428 | 17.15219124 | CS |
52 | -24.34 | -71.0656934307 | 34.25 | 35.01 | 6.75 | 522428 | 17.15219124 | CS |
156 | -24.34 | -71.0656934307 | 34.25 | 35.01 | 6.75 | 522428 | 17.15219124 | CS |
260 | -24.34 | -71.0656934307 | 34.25 | 35.01 | 6.75 | 522428 | 17.15219124 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions